After commercial edibles became legally available in 2019, cannabis-related exposures were seen to be responsible for nearly 10 percent of all ED visits for poisonings in Ontario.
Doctors in Canada can now request psychedelic-assisted therapies for their patients through a new program, following an amendment to Health Canada’s Special Access Program (SAP).
Technology Networks spoke to the co-founder of Field Trip Health, a Toronto-based provider of ketamine therapy, on why 2021 was such a significant year for psychedelics.
The company behind the trial has expanded it to include three other behavioral addictions: binge eating disorder, compulsive sexual behavior and internet gaming disorder.
To discuss the chromatographic challenges posed by novel cannabinoids, Analytical Cannabis recently spoke with Sean Orlowicz, business development manager for food and cannabis at Phenomenex.
A group of researchers at the University of Mississippi School of Pharmacy have been awarded a $1.37 million grant to study whether cannabis compounds can treat HIV-related pain.
In this article, Technology Networks considers how qPCR works, experimental requirements, data analysis and applications of the technique.
The researchers came to their conclusion after providing the drug to participants of a controlled trial of psilocybin-mediated therapy.